In MS lesions (Table 1), the predominant cell set expressing these receptors is microglia, with TLR2 being the most prominently expressed TLR in the chronic mixed active/inactive lesion edge (in AIMS, MIMS and oligodendrocytes). This evidence concerns the gene TLR2 and myeloid sarcoma.